At Philips, we deliver advanced molecular imaging solutions that help you to seamlessly connect data, technology and people across the care continuum. Because today health knows no bounds, and neither should healthcare.
Let’s work together to advance healthcare.
Featuring presentations by special guest speakers:
Dr. Jay Kikut, Director of the Department of Nuclear Medicine and PET at the University of Vermont Medical Center, discusses the benefits of Philips Vereos Digital PET/CT scanner and how improved small lesion detectability, fast scanning and low PET dose impacts patient care.
Supported by rigorous clinical evidence, Vereos is the world’s first and only fully digital, clinically proven, PET/CT solution. Vereos offers improved detectability and characterization of small lesions1 and uncompromised lesion detectability in one tenth of the time2.
Ease the patient experience while facilitating excellent clinical conditions during each procedural step of the imaging exam with Ambient Experience. Dynamic lighting, projection, and sound provide a positive distraction for patients.
Specifically designed for nuclear cardiology, the Philips CardioMD IV is a clinically-proven SPECT system tailored to enhance your workflow and add value to your practice.
The latest edition of Philips' comprehensive advanced visualization and analysis platform, IntelliSpace Portal 10, provides enterprise-wide access to a comprehensive suite of Molecular Imaging processing and review applications.
1 Nguyen NC, Image Quality and Diagnostic Performance of a Digital PET Prototype in Patients with Oncologic Diseases: Initial Experience and Comparison with Analog PET, J Nucl Med 2015; 56:1378–1385
2 Zhang J., Evaluation of speed of PET acquisition: How fast can we go? - A validation of list mode PET simulation approach with true acquisitions, SNMMI 2017
You are about to visit a Philips global content page
Continue
What's trending
News